Inhalon Biopharma Inc.
PrivateLast Round
Grant
Nov 15, 2023
Total Funding Raised
$21.3M
Momentum Score
25 /100
Company Overview
Inhalon Biopharma Inc. is a clinical-stage biotechnology company developing inhaled antibody treatments for acute respiratory infections such as RSV, influenza, and SARS-CoV-2.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inhalon Biopharma Inc. Comps
Public and private peers based on sector, stage, and business model.
Inhalon Biopharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 15, 2023 | ||||
| Series A | Jun 30, 2022 | ||||
| Grant | May 26, 2021 | ||||
| Seed | Aug 26, 2020 | ||||
| Seed | Mar 20, 2019 |
Inhalon Biopharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JSR Life Sciences | Series A |
| Life Science Angels | Series A, Seed |
| Band of Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2025
Human challenge trial initiated for RSV treatment.
Inhalon Biopharma Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inhalon Biopharma Inc.'s valuation, stock price, and market status.
